Literature DB >> 23018641

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.

Vinod Pant1, Alfonso Quintás-Cardama, Guillermina Lozano.   

Abstract

Aberrations in the p53 tumor suppressor pathway are associated with hematologic malignancies. p53-dependent cell cycle control, senescence, and apoptosis functions are actively involved in maintaining hematopoietic homeostasis under normal and stress conditions. Whereas loss of p53 function promotes leukemia and lymphoma development in humans and mice, increased p53 activity inhibits hematopoietic stem cell function and results in myelodysplasia. Thus, exquisite regulation of p53 activity is critical for homeostasis. Most of our understanding of p53 function in hematopoiesis is derived from genetically engineered mice. Here we summarize some of these models, the various mechanisms that disrupt the regulation of p53 activity, and their relevance to human disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018641      PMCID: PMC3537308          DOI: 10.1182/blood-2012-05-356014

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  143 in total

1.  Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models.

Authors:  Tamara Terzian; Melissa Dumble; Farinaz Arbab; Christina Thaller; Lawrence A Donehower; Guillermina Lozano; Monica J Justice; Dennis R Roop; Neil F Box
Journal:  J Pathol       Date:  2011-06-14       Impact factor: 7.996

2.  p53 lesions in leukemic transformation.

Authors:  Ashot Harutyunyan; Thorsten Klampfl; Mario Cazzola; Robert Kralovics
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

3.  Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability.

Authors:  Vinod Pant; Shunbin Xiong; Tomoo Iwakuma; Alfonso Quintás-Cardama; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

4.  Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity.

Authors:  Yunyuan V Wang; Mathias Leblanc; Norma Fox; Jian-Hua Mao; Kelsey L Tinkum; Kurt Krummel; Dannielle Engle; David Piwnica-Worms; Helen Piwnica-Worms; Allan Balmain; Kenneth Kaushansky; Geoffrey M Wahl
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

5.  Validation of MdmX as a therapeutic target for reactivating p53 in tumors.

Authors:  Daniel Garcia; Matthew R Warr; Carla P Martins; Lamorna Brown Swigart; Emmanuelle Passegué; Gerard I Evan
Journal:  Genes Dev       Date:  2011-08-15       Impact factor: 11.361

6.  Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects.

Authors:  Nadia Danilova; Kathleen M Sakamoto; Shuo Lin
Journal:  Br J Haematol       Date:  2010-11-29       Impact factor: 6.998

Review 7.  Animal models of Diamond Blackfan anemia.

Authors:  Kelly A McGowan; Philip J Mason
Journal:  Semin Hematol       Date:  2011-04       Impact factor: 3.851

8.  Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.

Authors:  Shilpee Dutt; Anupama Narla; Katherine Lin; Ann Mullally; Nirmalee Abayasekara; Christine Megerdichian; Frederick H Wilson; Treeve Currie; Arati Khanna-Gupta; Nancy Berliner; Jeffery L Kutok; Benjamin L Ebert
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

Review 9.  Do reactive oxygen species play a role in myeloid leukemias?

Authors:  Paul Spencer Hole; Richard Lawrence Darley; Alex Tonks
Journal:  Blood       Date:  2011-03-11       Impact factor: 22.113

Review 10.  Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.

Authors:  Sean M Post; Vinod Pant; Hussein Abbas; Alfonso Quintás-Cardama
Journal:  Oncotarget       Date:  2010-07
View more
  51 in total

1.  MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1.

Authors:  Hakim Bouamar; Daifeng Jiang; Long Wang; An-Ping Lin; Manoela Ortega; Ricardo C T Aguiar
Journal:  Mol Cell Biol       Date:  2015-02-02       Impact factor: 4.272

2.  Expansion of the hematopoietic stem cell compartment is necessary but not sufficient for gain-of-function mutant p53 R248Q to accelerate lymphomagenesis.

Authors:  A R Yallowitz; W Hanel; U M Moll
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

3.  Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.

Authors:  T Tsuruta-Kishino; J Koya; K Kataoka; K Narukawa; Y Sumitomo; H Kobayashi; T Sato; M Kurokawa
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

4.  Genetically engineered mouse models for studying radiation biology.

Authors:  Katherine D Castle; Mark Chen; Amy J Wisdom; David G Kirsch
Journal:  Transl Cancer Res       Date:  2017-07       Impact factor: 1.241

Review 5.  Deconstructing networks of p53-mediated tumor suppression in vivo.

Authors:  Alyssa M Kaiser; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

Review 6.  Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.

Authors:  Ruoji Zhou; An Xu; Julian Gingold; Louise C Strong; Ruiying Zhao; Dung-Fang Lee
Journal:  Trends Pharmacol Sci       Date:  2017-08-14       Impact factor: 14.819

7.  Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.

Authors:  Hemanth Tummala; Amanda Walne; Laura Collopy; Shirleny Cardoso; Josu de la Fuente; Sarah Lawson; James Powell; Nicola Cooper; Alison Foster; Shehla Mohammed; Vincent Plagnol; Thomas Vulliamy; Inderjeet Dokal
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

Review 8.  DNA damage response, redox status and hematopoiesis.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Cells Mol Dis       Date:  2013-09-13       Impact factor: 3.039

9.  Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.

Authors:  Michael I Carr; Justine E Roderick; Hugh S Gannon; Michelle A Kelliher; Stephen N Jones
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

10.  Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis.

Authors:  Chang-Lung Lee; Jordan M Blum; David G Kirsch
Journal:  Transl Cancer Res       Date:  2013-10       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.